Bou About Ghina, Thiebault Emilie, Wattenhofer-Donzé Marie, Jacobs Hugues, Guimond Alain, Sorg Tania, Robinet Eric, Baumert Thomas F, Monassier Laurent, Herault Yann
Institut Clinique de la Souris, PHENOMIN-ICS, Illkirch, France.
Institute of Image-Guided Surgery, University of Strasbourg, Strasbourg, France.
Curr Protoc Mouse Biol. 2019 Jun;9(2):e62. doi: 10.1002/cpmo.62. Epub 2019 May 30.
Hepatocellular carcinoma (HCC) is the second leading cause of cancer death worldwide. While curative approaches for early stage HCC exist, effective treatment options for advanced HCC are lacking. Furthermore, there are no efficient chemopreventive strategies to limit HCC development once cirrhosis is established. One challenge for drug development is unsatisfactory animal models. In this article, we describe an orthotopic xenograft mouse model of human liver cancer cell lines through image-guided injection into the liver. This technique provides a less invasive yet highly efficient approach to engraft human HCC into mouse liver. Similarly, image-guided injections are used to deliver chemotherapeutics locally, enabling reduction in potential systemic adverse effects, while reducing the required dose for a therapeutic effect. In summary, this image-guided strategy provides a novel and convenient approach to improve current HCC mouse models. © 2019 The Authors. This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
肝细胞癌(HCC)是全球第二大致癌死亡原因。虽然存在针对早期HCC的治愈性方法,但晚期HCC缺乏有效的治疗选择。此外,一旦肝硬化形成,就没有有效的化学预防策略来限制HCC的发展。药物开发面临的一个挑战是动物模型不尽人意。在本文中,我们描述了一种通过图像引导将人肝癌细胞系注射到肝脏中的原位异种移植小鼠模型。该技术提供了一种侵入性较小但高效的方法,可将人HCC植入小鼠肝脏。同样,图像引导注射用于局部递送化疗药物,既能减少潜在的全身不良反应,又能降低产生治疗效果所需的剂量。总之,这种图像引导策略为改进当前的HCC小鼠模型提供了一种新颖且便捷的方法。© 2019作者。本文是一篇开放获取文章,遵循知识共享署名-非商业性使用-禁止演绎许可协议,允许在任何媒介中使用和传播,前提是正确引用原始作品,使用是非商业性的,且不进行任何修改或改编。